Ocaliva
FDA Warns Providers About Prescribing Ocaliva in Patients With PBC and Advanced Cirrhosis
The FDA is warning physicians not to prescribe obeticholic acid (Ocaliva, Intercept) to patients with primary ...
MAY 27, 2021
Trial Results Mixed for Frontrunning NASH Therapy
For treatment of non-alcoholic steatohepatitis, obeticholic acid (OCA) met one of its primary end points but not ...
MARCH 13, 2020
Pipeline Rich for Bile Acid Drugs
Arlington, Va.—Hepatologists treating patients with cholangiopathies have had few options. But that might be ...
OCTOBER 3, 2018
FDA Adds Boxed Warning to Ocaliva Label to Highlight Correct Dosing
The FDA issued a Drug Safety Communication related to obeticholic acid (Ocaliva, Intercept), warning that the drug ...
FEBRUARY 2, 2018
Load more